Cellino's Solution
Founded in 2017, Cellino has developed self-contained units called cassettes, likened to "Nespresso pods," which can grow personalized cell treatments on-site at hospitals. This technology has garnered significant attention, including a $25 million grant from the federal government's Advanced Research Projects Agency for Health (ARPA-H) and $96 million in venture capital funding.